COAG Latest Press Releases

-- November 11, 2026 --

Hemab Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- November 10, 2026 --

Hemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- November 9, 2026 --

Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia Globe Newswire 7:00 AM

-- November 4, 2026 --

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition Globe Newswire 9:05 AM

-- November 3, 2026 --

Hemab Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 10, 2026 Globe Newswire 7:00 AM

-- September 24, 2026 --

Hemab Therapeutics Strengthens Board of Directors with Appointment of Keli Walbert Globe Newswire 4:01 PM

-- September 17, 2026 --

Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding Globe Newswire 8:00 AM

-- August 17, 2026 --

/C O R R E C T I O N -- The Galien Foundation/ PRNewswire 4:15 AM

-- August 13, 2026 --

The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup" PRNewswire 9:00 AM

-- August 11, 2026 --

Hemab Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 14, 2026 --

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress Globe Newswire 7:45 AM

-- July 12, 2026 --

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress Globe Newswire 6:28 AM

-- June 26, 2026 --

Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the ISTH 2026 Congress Globe Newswire 9:00 AM

Market Data Delayed 15 Minutes